Skip to content

H.R. 1418 · 118th Congress (2023–2025)

Animal Drug and Animal Generic Drug User Fee Amendments of 2023

This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.

The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).

Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.

Expired in Senate

Derived from the legislative history, not an official disposition.

This bill’s path

132 days after it was introduced

This is H.R. 1418’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced4 months

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Greg Pence (R-IN-6)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Rep. Kim Schrier (D-WA-8)· Original · Mar 7, 2023
  2. Rep. Susie Lee (D-NV-3)· Later · Jun 6, 2023
Policy area
Health
Subjects
  • Research and development
  • User charges and fees
  • Veterinary medicine and animal diseases

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. ▸ 7 committee actions · Mar 7, 2023 – Jun 9, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held.

      Sources
    4. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 0 .

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    6. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.

      Sources
    7. Reported by committee

      Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-104.

      Sources
  3. Latest

    Passed House

    Congressional Record H3620–H3623

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    The House passed the bill as amended.

    Document: Engrossed in House

    Sources
  4. Expired

    Passed House → Placed on calendar → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Mar 7, 2023 · Markup May 24, 2023 · Reported Jun 9, 2023H. Rept. 118-104
    1. May 24, 2023 · Markup

    1. H. Rept. 118-104 · Jun 9, 2023 · Animal Drug and Animal Generic Drug User Fee Amendments of 2023
  2. HouseHealthReferred Mar 17, 2023 · Markup May 17, 2023 · Reported May 17, 2023
    1. May 17, 2023 · Meeting

    2. Mar 30, 2023 · Hearing

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Jul 17, 2023 · House · Considered under suspension of the rulesCongressional Record H3620–H3624

    Animal Drug and Animal Generic Drug User Fee Amendments of 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Placed on Calendar Senate
Titles (5)
  1. Animal Drug and Animal Generic Drug User Fee Amendments of 2023

    Display title, Short title · Placed on Calendar Senate, Reported in House, Engrossed in House

  2. Animal Generic Drug User Fee Amendments of 2023

    Short title · Placed on Calendar Senate, Introduced in House, Reported in House, Engrossed in House · portion of the bill

  3. Animal Drug User Fee Amendments of 2023

    Short title · Placed on Calendar Senate, Introduced in House, Reported in House, Engrossed in House · portion of the bill

  4. Animal Drug User Fee Amendments of 2023

    Short title · Introduced in House

  5. To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.

    Official title · Introduced in House